Skip to content

A test to assess blood glucose responses after intake of frozen desserts.

A test to assess blood glucose responses after intake of frozen desserts. - A test to assess blood glucose responses after intake of frozen desserts.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000050725
Enrollment
13
Registered
2023-05-01
Start date
2023-02-16
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

borderline diabetics

Interventions

Ingestion of test foods (research foods 1) Ingestion of test foods (research foods 2)

Sponsors

Ezaki Glico Co., Ltd
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Japanese male and female between 20 and 59 years of age. 2. borderline diabetics or fasting blood glucose level is 110 mg/dL to 125 mg/dL or HbA1c level is 6.0% to 6.5% 3. Written informed is required.

Exclusion criteria

Exclusion criteria: 1. Subjects who are allergic to the test food's products 2. Patients under treatment, or on medication 3. Subjects having cardiac arrhyhmia, or severe anemia 4. Subjectsl taking antipertensive drugs, etc 5. Subjects who regularly have symptoms such as dizziness, lightheadedness, palpitations, headache, shortness of breath, etc 6. Subjects who have donated more than 200 mL of blood within the last 2 months or more than 400 mL within the last 3 months 7. Subjects with a history of diabetes in the past 8. Subjects with a history of serious diseases (liver disorder, renal disorder, heart disease, etc.) in the past 9. Subjects with a history of digestive disorders in the past 10. Subjects with a history of hepatitis in the past or having hepatitis now 11. Alcoholic patients 12. Subjects who are pregnant, lactating, or planning to become pregnant during this trial 13. Subjects taking antidiabetic drug or health foods that claim to affect blood sugar levels 14. Subjects in ohther clinical trial

Design outcomes

Primary

MeasureTime frame
the postprandial blood glucose level

Countries

Japan

Contacts

Public ContactTakayoshi Machida

Ezaki Glico Co., Ltd Health Innovation Business Headquarter

takayoshi.machida@glico.com080-8932-0881

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026